Assessment of cardiovascular & pulmonary pathobiology in vivo during acute COVID-19
Document Type
Article
Department
Imaging and Diagnostic Radiology (East Africa)
Abstract
Importance Acute COVID-19-related myocardial, pulmonary and vascular pathology, and how these relate to each other, remains unclear. No studies have used complementary imaging techniques, including molecular imaging, to elucidate this.
Objective We used multimodality imaging and biochemical sampling in vivo to identify the pathobiology of acute COVID-19.
Design, Setting and Participants Consecutive patients presenting with acute COVID-19 were recruited during hospital admission in a prospective cross-sectional study. Imaging involved computed-tomography coronary-angiography (CTCA - identified coronary disease), cardiac 2-deoxy-2-[fluorine-18]fluoro-D-glucose positron-emission tomography/computed-tomography (18F-FDG-PET/CT - identified vascular, cardiac and pulmonary inflammatory cell infiltration) and cardiac magnetic-resonance (CMR – identified myocardial disease), alongside biomarker sampling.
Results Of 33 patients (median age 51 years, 94% male), 24 (73%) had respiratory symptoms, with the remainder having non-specific viral symptoms. Nine patients (35%, n=9/25) had CMR defined myocarditis. 53% (n=5/8) of these patients had myocardial inflammatory cell infiltration. Two patients (5%) had elevated troponin levels. Cardiac troponin concentrations were not significantly higher in patients with myocarditis (8.4ng/L [IQR 4.0-55.3] vs 3.5ng/L [2.5-5.5], p=0.07) or myocardial cell infiltration (4.4ng/L [3.4-8.3] vs 3.5ng/L [2.8-7.2], p=0.89). No patients had obstructive coronary artery disease or vasculitis. Pulmonary inflammation and consolidation (percentage of total lung volume) was 17% (IQR 5-31%) and 11% (7-18%) respectively. Neither were associated with presence of myocarditis.
Conclusions and relevance Myocarditis was present in a third patients with acute COVID-19, and the majority had inflammatory cell infiltration. Pneumonitis was ubiquitous, but this inflammation was not associated with myocarditis. The mechanism of cardiac pathology is non-ischaemic, and not due to a vasculitic process.
Question What is the pathobiology of the cardiac, pulmonary and vascular systems during acute COVID-19 infection ?
Findings Over a third of patients with acute COVID-19 had myocarditis by cardiac MRI criteria. Myocardial inflammatory cell infiltration was present in about two thirds of patients with myocarditis. No associations were observed between the degree of pulmonary involvement and presence of myocarditis. There was no evidence of obstructive coronary artery disease or evidence of large vessel vasculitis.
Publication (Name of Journal)
medRxiv
Recommended Citation
Alam, S.,
Vinayak, S.,
al, e.
(2022). Assessment of cardiovascular & pulmonary pathobiology in vivo during acute COVID-19. medRxiv.
Available at:
https://ecommons.aku.edu/eastafrica_fhs_mc_imaging_diagn_radiol/57
Comments
Pre-print